Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (201-210 of 279) with videos related to

Pageof 28
Sort By:
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Cancer Cell|February 8, 2011
Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathwaysLüder Hinrich Meyer, Sarah Mirjam Eckhoff, Manon Queudeville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Haematologica|April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemiaJanina Heilmann, Simon Vieth, Anja Möricke, et al.
Oncogene|January 18, 2019
Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repairMarcos Seoane, Sophia Buhs, Pablo Iglesias, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Blood|July 18, 2024
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcomeMarcel Te Vrugt, Janna Wessolowski, Gerrit Randau, et al.
Blood Advances|April 14, 2026
Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-RFriederike Meyer-Wentrup, Sarah Flora Jonas, Fabian Knörr, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2021
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trialsCornelia Eckert, Catriona Parker, Anthony V Moorman, et al.
Pageof 28

Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Cancer Cell|February 8, 2011
Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathwaysLüder Hinrich Meyer, Sarah Mirjam Eckhoff, Manon Queudeville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Haematologica|April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemiaJanina Heilmann, Simon Vieth, Anja Möricke, et al.
Oncogene|January 18, 2019
Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repairMarcos Seoane, Sophia Buhs, Pablo Iglesias, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Blood|July 18, 2024
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcomeMarcel Te Vrugt, Janna Wessolowski, Gerrit Randau, et al.
Blood Advances|April 14, 2026
Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-RFriederike Meyer-Wentrup, Sarah Flora Jonas, Fabian Knörr, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2021
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trialsCornelia Eckert, Catriona Parker, Anthony V Moorman, et al.
Pageof 28